Package Leaflet: Information for the User
CARDURAN NEO 4 mg modified-release tablets
Doxazosin
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Carduran Neo is a vasodilator medicine used to treat high blood pressure and benign prostatic hyperplasia.
Carduran Neo is indicated for the treatment of high blood pressure in the arteries (hypertension) and for the treatment of urinary flow obstruction and irritative symptoms associated with benign prostatic hyperplasia (BPH).
Carduran Neo can be used in patients with BPH, whether they are hypertensive or normotensive. Patients with both conditions can be treated with Carduran Neo as monotherapy.
Treatment with Carduran Neo requires periodic monitoring by your doctor.
Do not take Carduran Neo
Warnings and precautions
Consult your doctor before starting to use Carduran Neo if:
Especially at the start of treatment with this medicine, dizziness, weaknessand, in rare cases, fainting can occur. Therefore, caution should be exercised when starting treatment, and situations that could cause injury if such symptoms occur should be avoided.
Before starting treatment with Carduran Neo, your doctor may perform tests to rule out other diseases such as prostate cancer that may cause the same symptoms as benign prostatic hyperplasia.
If you are going to undergo eye surgeryfor cataracts, please inform your doctor before the operation if you are taking or have taken Carduran Neo. This is because Carduran Neo can cause complications during surgery, which can be taken into account and controlled by your ophthalmologist if they have been previously informed.
Prolonged and painful erectionscan occur very rarely. If this happens, consult a doctor urgently.
Using Carduran Neo with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Carduran Neo has been given with other antihypertensives, other medicines such as non-steroidal anti-inflammatory drugs, antibiotics, oral antidiabetics, gout medicines, anticoagulants, digoxin, warfarin, phenytoin, and indomethacin without any negative consequences. Doxazosin enhances the action of other antihypertensives in lowering blood pressure.
Consult your doctor or pharmacist before using Carduran Neo if you are taking any of the following medicines, as they may change the effect of Carduran Neo:
Taking Carduran Neo with food and drinks
Carduran Neo can be taken with or without food.
Children and adolescents
Carduran Neo is not recommended for use in children and adolescents under 18 years of age, as safety and efficacy have not been established.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Doxazosin, the active substance of Carduran Neo, may appear in breast milk in small amounts. You should not take Carduran Neo while breastfeeding your baby unless your doctor recommends it.
Driving and using machines
Your ability to drive or operate machinery may be impaired, especially at the start of treatment with Carduran Neo.
Carduran Neo contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially “sodium-free”.
Follow exactly the instructions of administration of Carduran Neo given by your doctor. If you are unsure, consult your doctor or pharmacist again.
Your doctor will decide what dose of Carduran Neo is most suitable for you. Do not take more tablets than prescribed by your doctor.
Depending on the individual response, the doctor may modify the dose of Carduran Neo.
Carduran Neo is given orally.
The initial dose is one tablet (4 mg) once daily. The optimal effect is achieved at four weeks. If necessary, after this period, the dose can be increased to a single daily dose of 8 mg, depending on the patient's response.
The maximum dose is 8 mg in a single daily dose.
No dose adjustment is necessary in elderly patients (over 65 years) and patients with renal insufficiency.
Carduran Neo can be administered in the morning or at night.
All dose modifications and monitoring will be carried out under medical supervision.
Carduran Neo can be administered with other medicines used to treat high blood pressure and benign prostatic hyperplasia (BPH) that your doctor has prescribed.
Instructions for correct administration
Swallow the Carduran Neo tablet whole, without chewing, dividing, or crushing.
Swallow the tablets with a sufficient amount of liquid (e.g. a glass of water).
In Carduran Neo, the medication is inside a non-absorbable tablet, specially designed for controlled release of the active substance. When this process is complete, the empty tablet is eliminated from the body through the feces.
Take Carduran Neo once daily, every day, and approximately at the same time. Taking the tablets at the same time each day will have a better effect on your blood pressure. It will also help you remember when to take the tablets. Carduran Neo can be taken during meals or outside of meals.
Follow these instructions unless your doctor has given you different instructions.
Remember to take your medicine.
Your doctor will indicate the duration of your treatment with Carduran Neo. Do not stop treatment before, as it may be harmful to your health.
If you feel that the effect of Carduran Neo is too strong or too weak, consult your doctor or pharmacist. Do not take more tablets than recommended by the doctor.
If you take more Carduran Neo than you should:
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, telephone: 91 562 04 20 (indicating the medicine and the amount ingested).
An overdose of Carduran Neo can cause a drop in blood pressure. In this case, sit with your head down.
If you forget to take Carduran Neo:
Do not take a double dose to make up for forgotten doses. It is important that you take Carduran Neo regularly at the same time each day. If you forget to take a dose, take it as soon as you can. However, if it is almost time for the next dose, do not take the missed tablet.
If you stop treatment with Carduran Neo
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Doxazosin reactions vary in intensity from one individual to another and should be taken into account, especially at the start of treatment or when changing medication, and are generally mild.
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Side effects of unknown frequency (frequency cannot be estimated from the available data):
IFIS (Intraoperative Floppy Iris Syndrome, a certain eye disorder that can occur during cataract surgery)
Entry of semen into the bladder during ejaculation (retrograde ejaculation)
No differences in adverse events were observed between young and elderly patients.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: http://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store in a dry place.
Do not store above 30°C.
Store in the original package.
Do not use this medicine after the expiry date which is stated on the carton after “EXP”. The expiry date refers to the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Carduran Neo 4 mg modified-release tablets
Core of the tablet: polyethylene oxide, sodium chloride, hypromellose, red iron oxide (E172), and magnesium stearate
Coating of the tablet: cellulose acetate, macrogol 3350, hypromellose, titanium dioxide (E171), printing ink (shellac, black iron oxide (E172), isopropyl alcohol, ammonia, and propylene glycol).
Appearance and packaging
Carduran Neo 4 mg tablets are modified-release, film-coated, white, round, biconvex tablets with a hole in one face printed with “CXL 4”.
Carduran Neo 4 mg modified-release tablets are available in packs of 28 tablets.
Other presentations:
Carduran Neo 8 mg modified-release tablets
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer
Pfizer Manufacturing Deutschland GmbH,
Mooswaldallee 1
79108 Freiburg Im Breisgau
Germany
You can obtain further information on this medicine by contacting the local representative of the marketing authorisation holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 Madrid
Spain
Date of last revision of this leaflet: December 2018
Other sources of information
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of CARDURAN NEO 4 mg MODIFIED-RELEASE TABLETS in October, 2025 is around 7.27 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.